I have just listened to the interview. This is a brilliant concept, which will streamline accounting processes.
No more chasing staff around for invoices. The companies can set spending limits to avoid staff overspending, which is a common problem and very hard to rectify after the event.
Not to mention that it takes the hard work out of VAT/GST etc.
I bought this initially as a short term trade, but after watching this, I am very excited to add to my investment and hold this for long term.
What a unique and much needed product. It is also great to see that they have their product patented, to make it that little bit harder for others to replicate it.
This is all imo. Please dyor.
- Forums
- ASX - By Stock
- W2V Media updates.
I have just listened to the interview. This is a brilliant...
Featured News
Add W2V (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
-0.001(11.1%) |
Mkt cap ! $7.256M |
Open | High | Low | Value | Volume |
0.8¢ | 0.8¢ | 0.8¢ | $712 | 89K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 72726 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 3841261 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 72726 | 0.008 |
4 | 1866000 | 0.007 |
11 | 4661676 | 0.006 |
4 | 1535000 | 0.005 |
1 | 500000 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 3841261 | 9 |
0.010 | 5492952 | 5 |
0.011 | 5026189 | 8 |
0.012 | 666583 | 2 |
0.014 | 200000 | 1 |
Last trade - 15.45pm 12/11/2024 (20 minute delay) ? |
Featured News
W2V (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online